Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Juric

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Engineering Endogenous T Cell Receptors to Recognize Cancer Neoantigens Using a Hybrid Physics-AI ApproachJeffrey K Weber, Gyanu Parajuli, Stephen Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPGHolly B Lindsay, Catherine A Billups, Mehmet Kocak, et al.
Nature Cancer|January 2, 2026
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancerNadeem Riaz, Tyler J Alban, Robert I Haddad, et al.
Nature Genetics|July 11, 2022
Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunityXiaoxiao Ma, Nadeem Riaz, Robert M Samstein, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Platelets regulate glioblastoma growth and immunity via sex-dependent PAR4 - Estrogen receptor beta signalingAnthony R Sloan, George Bukenya, Gavin P Tannish, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Engineering Endogenous T Cell Receptors to Recognize Cancer Neoantigens Using a Hybrid Physics-AI ApproachJeffrey K Weber, Gyanu Parajuli, Stephen Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPGHolly B Lindsay, Catherine A Billups, Mehmet Kocak, et al.
Nature Cancer|January 2, 2026
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancerNadeem Riaz, Tyler J Alban, Robert I Haddad, et al.
Nature Genetics|July 11, 2022
Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunityXiaoxiao Ma, Nadeem Riaz, Robert M Samstein, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Platelets regulate glioblastoma growth and immunity via sex-dependent PAR4 - Estrogen receptor beta signalingAnthony R Sloan, George Bukenya, Gavin P Tannish, et al.
Pageof 3